Do not combine any medications without consulting a medical provider first
A notable limitation of these agents is the need for continuous treatment, as discontinuation has been associated with rebound weight gain (56)
Notably, SGLT-2is are medications of small molecular weight, with lower LogP oct than the permeation prediction index of BBB (listed in Table 2)
Certain conditions, such as a history of medullary thyroid carcinoma or pancreatitis, may make this medication unsuitable for you
Answers (8) Plz Consult directly with details Let others know if this answer was helpful Was this answer helpful
With the same doses of semaglutide, there was a resulting 2.1%, 0%, 0%, 2.5%, 4.7%, and 9.1% respective increases in the proportion of patients achieving a 10%, or greater, reduction in weight loss